Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxter healthcare ltd - glucose anhydrous; calcium chloride dihydrate; magnesium chloride hexahydrate; (s)-lactic acid; sodium chloride; potassium chloride; sodium bicarbonate - solution for haemofiltration - 1.1gram/1litre ; 257mg/1litre ; 102mg/1litre ; 270mg/1litre ; 6.13gram/1litre ; 298mg/1litre ; 2.94gram/1litre

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxter healthcare ltd - potassium chloride; sodium chloride; sodium bicarbonate; glucose anhydrous; calcium chloride dihydrate; magnesium chloride hexahydrate; (s)-lactic acid - solution for haemofiltration - 149mg/1litre ; 6.13gram/1litre ; 2.94gram/1litre ; 1.1gram/1litre ; 257mg/1litre ; 102mg/1litre ; 270mg/1litre

Taiwan - kinesisk - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

百特醫療產品股份有限公司 臺北市大安區敦化南路2段95號28樓 (12350071) - calcium chloride dihydrate;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;glucose anhydrous;;lactic acid;;sodium chloride;;sodium bicarbonate ( eq to sodium hydrogen carbonate);;potassium chloride - 透析用液劑 - 主成分 () ; calcium chloride dihydrate (4012000350) gm; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) gm; glucose anhydrous (4020000750) gm; lactic acid (9200005300) gm; sodium bicarbonate ( eq to sodium hydrogen carbonate) (4008000700) gm; potassium chloride (4012001800) gm; sodium chloride (4012002100) gm - hemodialytics, concentrates - 連續性血液過濾或連續性血液透析過濾所使用的補充液,連續性血液透析或連續性血液透析過濾所使用之透析液。

Taiwan - kinesisk - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

百特醫療產品股份有限公司 臺北市大安區敦化南路2段95號28樓 (12350071) - calcium chloride dihydrate;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;glucose anhydrous;;lactic acid;;sodium chloride;;sodium bicarbonate ( eq to sodium hydrogen carbonate);;potassium chloride - 透析用液劑 - 主成分 () ; calcium chloride dihydrate (4012000350) gm; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) gm; glucose anhydrous (4020000750) gm; lactic acid (9200005300) gm; sodium bicarbonate ( eq to sodium hydrogen carbonate) (4008000700) gm; potassium chloride (4012001800) gm; sodium chloride (4012002100) gm - hemodialytics, concentrates - 連續性血液過濾或連續性血液透析過濾所使用的補充液,連續性血液透析或連續性血液透析過濾所使用之透析液。

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - calcium chloride dihydrate,glucose monohydrate,magnesium chloride hexahydrate,sodium bicarbonate,sodium chloride -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - calcium chloride dihydrate,glucose monohydrate,magnesium chloride hexahydrate,potassium chloride,sodium bicarbonate,sodium chloride -

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

alcon eye care uk ltd - sodium acid phosphate anhydrous; oxiglutatione; glucose; sodium bicarbonate; magnesium chloride hexahydrate; calcium chloride dihydrate; sodium chloride; potassium chloride - ocular irrigation solution - 420microgram/1ml ; 184microgram/1ml ; 920microgram/1ml ; 2.1mg/1ml ; 200microgram/1ml ; 154microgram/1ml ; 7.14mg/1ml ; 380microgram/1ml

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - magnesium chloride hexahydrate, quantity: 0.1017 g/l; sodium bicarbonate, quantity: 2.94 g/l; sodium chloride, quantity: 6.136 g/l; glucose monohydrate, quantity: 1.1 g/l (equivalent: glucose, qty 1 g/l); calcium chloride dihydrate, quantity: 0.2205 g/l - solution, dialysis - excipient ingredients: carbon dioxide; water for injections; hydrochloric acid; monobasic sodium phosphate dihydrate - replacement fluid, which is administered intravenously in patients with acute renal failure in intensive care units.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - glucose monohydrate, quantity: 1.1 g/l (equivalent: glucose, qty 1 g/l); sodium bicarbonate, quantity: 2.94 g/l; magnesium chloride hexahydrate, quantity: 0.1017 g/l; calcium chloride dihydrate, quantity: 0.2205 g/l; sodium chloride, quantity: 6.136 g/l; potassium chloride, quantity: 0.2982 g/l - solution, dialysis - excipient ingredients: water for injections; hydrochloric acid; carbon dioxide; monobasic sodium phosphate dihydrate - replacement fluid, which is administered intravenously in patients with acute renal failure in intensive care units.

Israel - engelsk - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose monohydrate (as anhydrous); lactic acid as sodium; magnesium chloride hexahydrate; sodium bicarbonate; sodium chloride - solution for peritoneal dialysis - sodium chloride 5.38 g/l; magnesium chloride hexahydrate 0.051 g/l; lactic acid as sodium 1.68 g/l; sodium bicarbonate 2.10 g/l; glucose monohydrate (as anhydrous) 13.6 g/l; calcium chloride dihydrate 0.184 g/l - sodium chloride - sodium chloride - physioneal is indicated whenever peritoneal dialysis is employed including:acute and chronic renal failure severe water retention severe electrolyte imbalance drug intoxication with dialysable substances when a more adequate therapeutic alternative is not available. bicarbonate/lactate based physioneal peritoneal dialysis solutions with a physiological ph are particularly indicated in patients in whom solutions based on lactate buffer only with a low ph cause abdominal inflow pain or discomfort.